Indonesia CT Scan Market Report 2023 to 2030

Indonesia CT Scan Market Analysis

$ 3999

Indonesia CT Scan Market was valued at $27.66Mn in 2023 and is predicted to grow at a CAGR of 7.87% from 2023 to 2030, to $47.01Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, increasing healthcare expenditure, and growing population and hospital development. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.

ID: IN10IDMD022 CATEGORY: Medical Devices GEOGRAPHY: Indonesia AUTHOR: Sarita Yadav

Buy Now

Indonesia CT Scan Market Executive Summary

Indonesia CT Scan Market was valued at $27.66 Mn in 2023 and is predicted to grow at a CAGR of 7.87% from 2023 to 2030, to $47.01 Mn by 2030.

A CT scan, or computed tomography scan, is a sophisticated imaging procedure that uses X-rays to produce detailed cross-sectional images of the body. Unlike traditional X-rays, CT scans capture multiple views from various angles, which a computer then processes into a three-dimensional representation of internal structures such as organs, bones, and soft tissues. Before the scan, patients may prepare by wearing a gown and removing metal objects. Depending on the type of scan, they might need to ingest a contrast material to enhance the visibility of specific tissues. During the scan, patients lie on a table that moves through a donut-shaped scanner while X-ray images are taken. Afterward, a radiologist interprets the images to diagnose conditions like cancer, heart disease, bone fractures, internal bleeding, and injuries. While CT scans offer detailed diagnostic capabilities, they involve radiation exposure and can be costly, though advancements have minimized risks and enhanced safety. Other imaging options like X-rays, ultrasound, and MRI scans are considered based on specific medical needs and radiation concerns.

A study using data from the Indonesian National Health Insurance (INHI) sample revealed a high prevalence of chronic multimorbidity among Indonesians, particularly in older age groups, with a prevalence odds ratio of 5.4-6.5 for those aged 60 and above. Additionally, the 2018 National Basic Health Survey reported a 3.8% prevalence of chronic kidney disease among adults aged 18 and above, with key risk factors including older age, hypertension, diabetes, and obesity. Despite these health challenges, a 2015 WHO health system review indicated that Indonesia had a relatively low availability of CT scan machines, with only 0.286 machines per Mn population.

The market therefore is driven by significant factors like the rising prevalence of chronic diseases, increasing healthcare expenditure, and growing population and hospital development. However, limited infrastructure and affordability, skilled workforce shortage, and reimbursement challenges restrict the growth and potential of the market.

A prominent player in this field is GE Healthcare, which launched a new refurbishing unit in Bangladesh for A1-Sure Ultrasound Systems, aiming to enhance accessibility to affordable ultrasound technology in developing regions, and Siemens Healthineers partnered with Microsoft to utilize Azure cloud services for AI-powered medical imaging solutions, aimed at advancing healthcare delivery with secure and scalable cloud computing. Other contributors include Canon Medical Systems, and NeuroLogica Corp. among others.

Indonesia CT Scan Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Rising Prevalence of Chronic Diseases: Indonesia faces a growing burden of chronic illnesses. The International Diabetes Federation estimates over 19.5 Mn Indonesians have diabetes in 2023. CT scans are vital for diagnosis and management, propelling market growth.

Increasing Healthcare Expenditure: Indonesia's healthcare spending is on the rise. Indonesian medical imaging market was valued at $375.8 Mn in 2023, and is projected to reach $567.5 Mn by 2030. This translates to more investment in CT scanners.

Growing Population and Hospital Development: Indonesia's population is projected to reach 299 Mn by 2030. This, coupled with government initiatives to build new hospitals, creates a rising demand for advanced diagnostic tools like CT scans.

Market Restraints

Limited Infrastructure and Affordability: Uneven distribution of medical facilities, particularly in rural areas, restricts access to CT scans. Additionally, the high cost of CT scanners can be a barrier for smaller hospitals, hindering widespread adoption.

Skilled Workforce Shortage: A lack of trained radiologists and technicians to operate and interpret CT scans can limit their effective utilization. This creates a bottleneck in the diagnostic process, impacting market growth.

Reimbursement Challenges: The current reimbursement system for CT scans in Indonesia can be complex and unpredictable. This can lead to higher out-of-pocket costs for patients, potentially discouraging them from seeking CT scan diagnostics.

Regulatory Landscape and Reimbursement Scenario

In Indonesia, the regulatory framework for the CT scan market is governed by the Ministry of Health, which oversees the approval and distribution of medical devices. All CT scanners must comply with national standards and obtain registration before being marketed in the country. This involves rigorous testing and certification to ensure safety and efficacy. Additionally, regulations stipulate that only licensed healthcare facilities with qualified personnel can operate CT scanners, ensuring that these devices are used appropriately and safely. The Indonesian government is also increasingly focusing on improving healthcare infrastructure, which includes updating regulations to accommodate advancements in medical technology.

Reimbursement for CT scans in Indonesia is primarily managed through the national health insurance scheme, Jaminan Kesehatan Nasional (JKN), administered by the Social Security Agency for Health (BPJS Kesehatan). While JKN covers a broad range of diagnostic services, including CT scans, reimbursement rates can be relatively low, which may not fully cover the costs incurred by healthcare providers. This can lead to disparities in access to advanced imaging services, particularly in rural areas where healthcare resources are limited. Private health insurance schemes may offer better reimbursement rates, but their coverage is limited to those who can afford such policies. Consequently, while regulatory and reimbursement frameworks exist to support the CT scan market, challenges remain in ensuring equitable access across different regions and population segments in Indonesia.

Competitive Landscape

Key Players

Here are some of the major key players in the Indonesia CT Scan Market:

GE HealthCare
Koninklijke Philips N.V.
Siemens Healthineers AG
Canon Medical Systems
NeuroLogica Corp.
Shanghai United Imaging Healthcare Co., Ltd.
Fujifilm Holdings Corporation
Shenzhen Anke High-tech Co., Ltd.
Koning Health
Carestream Dental LLC.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Indonesia CT Scan Market Segmentation

By Technology

High-end Slice CT
Mid-end Slice CT
Low-end Slice CT
Cone Beam CT (CBCT)

By Application

Oncology
Cardiology
Vascular
Neurology
Musculoskeletal
Others

By Modality

O-Arms
C- Arms

By End-User

Hospitals
Diagnostic Imaging Centers
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.